Forma Medical Secures FDA Clearance for Optimal Plating System, Enhancing MIS Forefoot Portfolio

Wednesday, July 10, 2024

Forma Medical, an innovator in medical device technology, is excited to announce the FDA 510(k) clearance of its OptimalMTP® Plating System.

This regulatory achievement represents a significant advancement in minimally invasive surgery (MIS), specifically targeting foot and ankle surgery—one of the fastest-growing areas in the medical device industry.

The OptimalMTP® Plating System is designed to meet the evolving needs of surgeons and patients, particularly for bunion-adjacent procedures.

Forma Medical aims to set new standards in MIS solutions by providing tailored, efficient, and effective options for these surgeries.

Leading the launch is the OptimalMTP®, the first plate and screw system focused on less invasive MTP fusion of the first ray.

This system, along with Forma Medical's existing forefoot products—OptimalHT® and OptimalAkin—demonstrates the company’s commitment to innovation and patient-centric solutions.

These products enable surgeons to tackle complex orthopedic challenges with high reproducibility and efficiency, reducing the invasiveness of procedures compared to current standards of care.

"The FDA clearance of our Optimal Plating System is a pivotal moment for both Forma Medical and the orthopedic community."

We are excited to introduce a platform that enhances surgical outcomes and elevates the standard of care for patients undergoing foot and ankle procedures.

Forma Medical is dedicated to driving innovation and collaboration in orthopedic surgery. By working closely with healthcare professionals, the company aims to deliver solutions that revolutionize patient care.

The FDA clearance of the Optimal Plating System underscores Forma Medical’s commitment to advancing orthopedic surgery and improving patient lives globally.